Latest Period
n/a
Security Snapshot
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) Institutional Ownership
CUSIP: 29405E208
13F Institutional Holders and Ownership History from Q2 2022 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.33
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- ENVB on Nasdaq
- Shares outstanding
- 1,022,530
- Price per share
- $0.33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 29405E208.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 18 to 0 between Q4 2024 and Q1 2025.
- Reported value moved from $386,721 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 29405E208?
CUSIP 29405E208 identifies ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29405E208:
Significant Owners of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Orca Capital AG | 4.9% | -42% | $32,016 | -$22,984 | 97,019 | -42% | Orca Capital AG | 31 Jan 2025 |
| AdvisorShares Trust | 1.7% | -77% | $5,601 | -$61,613 | 16,974 | -92% | AdvisorShares Trust | 31 Dec 2025 |
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$386,721 | $0.33 | 0 |
| 2024 Q4 | 1,079,100 | $386,721 | +$131,731 | $0.36 | 18 |
| 2024 Q3 | 711,295 | $337,193 | +$106,360 | $0.47 | 16 |
| 2024 Q2 | 505,777 | $307,294 | -$15,307 | $0.63 | 17 |
| 2024 Q1 | 488,227 | $488,359 | -$82,585 | $1.00 | 17 |
| 2023 Q4 | 489,047 | $635,757 | +$341,904 | $1.30 | 13 |
| 2023 Q3 | 222,867 | $518,348 | +$50,174 | $2.38 | 14 |
| 2023 Q2 | 187,040 | $630,094 | -$98,524 | $3.37 | 13 |
| 2023 Q1 | 227,883 | $382,412 | +$92,449 | $1.68 | 12 |
| 2022 Q4 | 172,925 | $356,768 | +$28,999 | $2.07 | 10 |
| 2022 Q3 | 147,300 | $622,000 | -$4,668,618 | $4.22 | 7 |
| 2022 Q2 | 1,252,390 | $268,000 | +$268,000 | $0.21 | 1 |